FDA Inspection 1307866 — Kumaran Deiva, MD, PhD
The FDA completed an inspection of Kumaran Deiva, MD, PhD on February 27, 2026 in Le Kremlin-Bicetre. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 27, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Le Kremlin-Bicetre (France)
Additional Details
Clinical Investigator (CI)